Abstract
Oral tumors are occassionally associated with hypercalcemia. Systemic symptoms due to hypercalcemia cause not only physical and mental troubles to patients but difficulties to physicians in choice of therapy and in prediction of prognosis since these symptoms resemble those seen at terminal stage of cancer. In the treatment of malignant hypercalcemia, simple, safe and efficient therapy that even cachectic cancer patients are able to toleate should be promptly performed.In the case reported here, a patient with tongue cancer diagnosed histologically squamous cell carcinoma, who manifested prominent hypercalcemia at a terminal stage of his clinical course was treated with synthetic eel calcitonin (Elcitonin). Administration of drug at a dosage of 160 MRCU/day intramusculary resulted in a significant decrease in serum calcium levels without notable side effects. Coadministration of glucocorticoid (Solu-Medral 250 mg/day) enhanced the effect of calcitonin.We, therefore, suggest that calcitonin with its known inhibitory action on bone resorption is one of the safest and most efficacious drugs for the treatment of hypercalcemia associated with oral cancers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
